Literature DB >> 23644216

Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole.

Hui-Zhen Zhang1, Guri L V Damu, Gui-Xin Cai, Cheng-He Zhou.   

Abstract

A novel series of benzimidazole type of Fluconazole analogues were synthesized and characterized by (1)H NMR, (13)C NMR, IR, MS and HRMS spectra. All the new compounds were screened for their antimicrobial activities in vitro by two-fold serial dilution technique. The bioactive evaluation showed that 3,5-bis(trifluoromethyl)phenyl benzimidazoles gave comparable or even stronger antibacterial and antifungal efficiency in comparison with reference drugs Chloromycin, Norfloxacin and Fluconazole. The combination of 2,4-difluorobenzyl benzimidazole derivative 5m and its hydrochloride 7 respectively with antibacterial Chloromycin, Norfloxacin or antifungal Fluconazole showed better antimicrobial efficiency with less dosage and broader antimicrobial spectrum than the separated use of them alone. Notably, these combined systems were more sensitive to Fluconazole-insensitive Aspergillus flavus and methicillin-resistant MRSA.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644216     DOI: 10.1016/j.ejmech.2013.03.049

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agents.

Authors:  Hojat-Allah Arab; Mohammad Ali Faramarzi; Nasrin Samadi; Hamid Irannejad; Alireza Foroumadi; Saeed Emami
Journal:  Mol Divers       Date:  2018-06-07       Impact factor: 2.943

2.  Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration.

Authors:  Yuan Zhang; Guri L V Damu; Sheng-Feng Cui; Jia-Li Mi; Vijai Kumar Reddy Tangadanchu; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-06-15       Impact factor: 3.597

3.  Synthesis, Characterization and Bioassay of Novel Substituted 1-(3-(1,3-Thiazol-2-yl)phenyl)-5-oxopyrrolidines.

Authors:  Birutė Sapijanskaitė-Banevič; Božena Šovkovaja; Rita Vaickelionienė; Jūratė Šiugždaitė; Eglė Mickevičiūtė
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

Review 4.  Importance of Fluorine in Benzazole Compounds.

Authors:  Thuraya Al-Harthy; Wajdi Zoghaib; Raid Abdel-Jalil
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

5.  Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential.

Authors:  Nevena Lj Stevanović; Ivana Aleksic; Jakob Kljun; Sanja Skaro Bogojevic; Aleksandar Veselinovic; Jasmina Nikodinovic-Runic; Iztok Turel; Miloš I Djuran; Biljana Đ Glišić
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-30

6.  An efficient one-pot conversion of carboxylic acids into benzimidazoles via an HBTU-promoted methodology.

Authors:  Leonard Barasa; Sabesan Yoganathan
Journal:  RSC Adv       Date:  2018-10-19       Impact factor: 4.036

7.  Design, synthesis, bio-evaluation, and in silico studies of some N-substituted 6-(chloro/nitro)-1H-benzimidazole derivatives as antimicrobial and anticancer agents.

Authors:  Em Canh Pham; Tuong Vi Thi Le; Tuyen Ngoc Truong
Journal:  RSC Adv       Date:  2022-08-03       Impact factor: 4.036

8.  Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents.

Authors:  Cheng-Ying Hsieh; Pi-Wen Ko; Yu-Jui Chang; Mohit Kapoor; Yu-Chuan Liang; Hui-Hsien Lin; Jia-Cherng Horng; Ming-Hua Hsu
Journal:  Molecules       Date:  2019-09-06       Impact factor: 4.411

Review 9.  Antimicrobial potential of 1H-benzo[d]imidazole scaffold: a review.

Authors:  Sumit Tahlan; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-02-04

10.  Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.

Authors:  Fat-Moon Suk; Chao-Lien Liu; Ming-Hua Hsu; Yu-Ting Chuang; Jack P Wang; Yi-Jen Liao
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.